CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response

Stefanie Stallard, Masha G. Savelieff, Kyle Wierzbicki, Brendan Mullan, Zachary Miklja, Amy Bruzek, Taylor Garcia, Ruby Siada, Bailey Anderson, Benjamin H. Singer, Rintaro Hashizume, Angel M. Carcaboso, Kaitlin Q. McMurray, Jason Heth, Karin Muraszko, Patricia L. Robertson, Rajen Mody, Sriram Venneti, Hugh Garton, Carl Koschmann

Research output: Contribution to journalLetter

9 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalActa Neuropathologica Communications
Volume6
Issue number1
DOIs
StatePublished - Aug 15 2018

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Stallard, S., Savelieff, M. G., Wierzbicki, K., Mullan, B., Miklja, Z., Bruzek, A., Garcia, T., Siada, R., Anderson, B., Singer, B. H., Hashizume, R., Carcaboso, A. M., McMurray, K. Q., Heth, J., Muraszko, K., Robertson, P. L., Mody, R., Venneti, S., Garton, H., & Koschmann, C. (2018). CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response. Acta Neuropathologica Communications, 6(1). https://doi.org/10.1186/s40478-018-0580-7